Jefferies & Company Inc. Lowers Price Target For Athenahealth (ATHN)

Analysts Richard Close at Jefferies & Company Inc. has released an update on Athenahealth, Inc. (NASDAQ: ATHN). The company has reported its first-quarter results.

Jefferies believes that Athenahealth’s first-quarter results were disappointing except for a 33% increase in revenue. Following the first-quarter results, the brokerage firm has lowered its price target for the company from $49 to $35.

Jefferies & Company has maintained its Buy rating for Athenhealth, Inc.